Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2006
11/16/2006US20060259993 Amidases, nucleic acids encoding them and methods for making and using them
11/16/2006US20060259988 Use of dg931 protein for treating diabetes, obesity and metabolic syndrome
11/16/2006US20060259987 Variants of antithrombin III
11/16/2006US20060258856 Method of isolating nucleic acids from stool samples
11/16/2006US20060258855 High resolution analysis of genetic variation within cryptosporidium parvum
11/16/2006US20060258850 Method for preparing human serum albumin through heat-treatment in the presence of divalent cation
11/16/2006US20060258840 Peroxisome proliferator-activated receptor
11/16/2006US20060258615 Administering to a mammal P1,P4-di(uridine 5'-)tetraphosphate, tetralithium salt; or P1,P4-di(uridine 5'-)tetraphosphate, tetrapotassium salt; in a pharmaceutically acceptable carrier to treat dry eye or retinal detachment
11/16/2006US20060258611 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference
11/16/2006US20060258610 Modulation of STAT 6 expression for the treatment of airway hyperresponsiveness
11/16/2006US20060258607 Ghrelin binding nucleic acids
11/16/2006US20060258606 Transforming growth factor-beta response element decoys and methods
11/16/2006US20060258596 Antimicrobial agents
11/16/2006US20060258593 Methods and compositions for the treatment of gastrointestinal disorders
11/16/2006US20060258576 Gdnf-related neuropeptides
11/16/2006US20060258574 Novel compositions and methods for the treatment of psoriasis
11/16/2006US20060258563 Nitrogen Oxide scavenging ability; digesting cytochrome c with restriction enzyme; use in prophylactic and therapeutics, measuring/treating nitrogen oxide concentrations in air, exhaust gas or water
11/16/2006US20060258554 Bgl6 beta-glucosidase and nucleic acids encoding the same
11/16/2006US20060257990 Carbonic anhydrase having increased stability under high temperature conditions
11/16/2006US20060257989 Truncated aggrecanase molecules
11/16/2006US20060257975 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers,
11/16/2006US20060257974 Vaccinia virus vector comprising a nucleic acid encoding a fusion protein amino acid sequence consisting of Vif, Vpr, Vpu, Vpx, Rev, Tat, and Nef; genetic vaccines for treating viral diseases
11/16/2006US20060257971 Antibodies to pro1561 polypeptide
11/16/2006US20060257970 Human HAC3
11/16/2006US20060257965 Extracellular matrix signalling molecules
11/16/2006US20060257959 Glucose dehydrogenase
11/16/2006US20060257947 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibdies and other binding agents
11/16/2006US20060257928 ANGE gene in atopy
11/16/2006US20060257921 Novel nucleic acid molecules and polypeptides encoding baboon TAFI
11/16/2006US20060257918 Polynucleotide encoding a novel human G-protein coupled receptor variant of the relaxin receptor HGPRBMY5v1, and variants thereof
11/16/2006US20060257917 Fluorescent dyes, energy transfer couples and methods
11/16/2006US20060257913 Genetic polymorphisms associated with myocardial infarction and uses thereof
11/16/2006US20060257912 Methods and sequences to suppress primate huntington gene expression
11/16/2006US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006US20060257906 Compositions comprising a library of analytes for detection, quantification and analyses
11/16/2006US20060257904 Agglomeration protein cascades, compositions and methods regarding the same
11/16/2006US20060257897 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/16/2006US20060257896 Splice variants, polynucleotide biomarkers, immunohistochemistry, non-invasive, for determining the state of a particular disease in the human body; for prognosis, prediction, screening, early diagnosis, staging, therapy selection and treatment monitoring of a marker-detectable disease such as cancer
11/16/2006US20060257894 Molecular typing of listeria monocytogenes, hybridization supports and kits for said molecular typing
11/16/2006US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006US20060257881 Oligonucleotides for detecting male infertility
11/16/2006US20060257880 Gastric and prostate cancer associated antigens
11/16/2006US20060257868 Tissue specific genes and gene clusters
11/16/2006US20060257867 Ghrelin binding nucleic acids
11/16/2006US20060257864 Primers designed on basis of the difference of sequences among staphylococcal enterotoxin subtypes
11/16/2006US20060257860 Compositions and assays to detect influenza virus A and B nucleic acids
11/16/2006US20060257857 Methods for identifying functionally related genes and drug targets
11/16/2006US20060257856 Heterodimeric receptor libraries using phagemids
11/16/2006US20060257852 Severe acute respiratory syndrome coronavirus
11/16/2006US20060257851 Bioinformatically detectable group of novel viral regulatory genes and uses thereof
11/16/2006US20060257500 TRPC6 involved in glomerulonephritis
11/16/2006US20060257421 Pneumolysin derivatives
11/16/2006US20060257409 Breast Specific Genes and Proteins
11/16/2006US20060257407 Anti-IL-6 antibodies, compositions, methods and uses
11/16/2006US20060257406 Immunoglobulin variable domain; tumor necrosis factor; competitve binding; surface plasmon resonance
11/16/2006US20060257399 Mixture comprising n-glycan modified antibodies exhibiting increased antibody-dependent cellular cytoxicity (ADCC); targeted destruction of tumor cells
11/16/2006US20060257387 Sugar chain synthase gene
11/16/2006US20060257367 Tumour-cell specific gene expression and its use in cancer therapy
11/16/2006DE102006020872A1 Verfahren zur Nucleinsäureisolierung und Vorrichtung zur Nucleinsäureisolierung A method for nucleic acid isolation and apparatus for nucleic acid isolation
11/16/2006DE102005023055A1 Making DNA fragments for determining DNA methylation pattern involves digesting DNA with methylation-specific restriction enzyme; and ligating adapters to restriction fragments, followed by primer mediated-amplification of ligated fragments
11/16/2006DE10010282B4 Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben Process for detection of cytosine methylation in DNA samples
11/16/2006CA2651376A1 Method for diagnosis and treatment of a mental disease
11/16/2006CA2607330A1 Plants containing a heterologous flavohemoglobin gene and methods of use thereof
11/16/2006CA2605015A1 Compositions and assays to detect influenza virus a and b nucleic acids
11/15/2006EP1721908A1 Novel method of synthesizing nucleic acid without protecting nucleotide bases
11/15/2006EP1721907A1 Silyl linker for solid-phase synthesis of nucleic acid
11/15/2006EP1721257A2 Differential expression of markers in ovarian cancer
11/15/2006EP1720990A2 High efficiency peptide production in plant cells
11/15/2006EP1720892A2 Branched polymeric sugars and nucleotides thereof
11/15/2006EP1720539A2 Schizochytrium fatty acid synthase (fas) and products and methods related thereto
11/15/2006EP1008351B1 Carcinostatic agents
11/15/2006EP0543942B2 Homogeneous assay system
11/15/2006CN1863928A Diagnostic and therapeutics for osteoporosis
11/15/2006CN1863923A Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
11/15/2006CN1863915A Lambda integrase mediated recombination in plants
11/15/2006CN1863818A Anti-VEGF antibodies
11/15/2006CN1863552A Tyrosinase mutant and methods of use thereof
11/15/2006CN1861800A Macroporous support for chemical amplification reactions
11/15/2006CN1861795A Product and process for transformation of thraustochytriales microorganisms
11/15/2006CN1284795C Magnetic nano particle nucleic acid separator, and its preparing method and use
11/14/2006US7135622 Mevalonate synthesis enzymes
11/14/2006US7135614 Brassica or helianthus plants having mutant delta-12 or delta-15 sequences
11/14/2006US7135613 Zebrafish emit green fluorescence under blue or ultraviolet light according to specificity of promoters in germ or somatic cells; capable of breeding to produce viable and fertile progeny
11/14/2006US7135611 Animal models for use in identifying modulators for treatment of obesity
11/14/2006US7135565 Synthesis of polynucleotides using combined oxidation/deprotection chemistry
11/14/2006US7135564 Reacting a linker arm cleaving the oligonucleotide having the desired sequence to produce a free oligonucleotide have the desired sequence; and a used linker arm; and recycling the used linker arm
11/14/2006US7135563 Screening for nucleotide sequences in sample; obtain sample, incubate with peptide nucleic acid probes, expose to antibodies, detect bound triplex structure, presence of bound triplex indicates presence of preferential nucleotide
11/14/2006US7135562 Avian iFABP gene expression controlling region
11/14/2006US7135561 Infectious bovine viral diarrhea virus clone
11/14/2006US7135560 Vectors; cells; drug targets
11/14/2006US7135559 Proteins and novel genes encoding the same
11/14/2006US7135558 Isolated Drosophila proteins essential for survival nucleic acid molecules encoding essential Drosophila proteins, and uses thereof as insecticidal targets
11/14/2006US7135338 Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism
11/14/2006US7135334 Stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more
11/14/2006US7135326 UDP-glucosyltransferases
11/14/2006US7135323 Microbially expressed thermotolerant phytase for animal feed
11/14/2006US7135321 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents
11/14/2006US7135320 Adaptor protein FRS2 and related products and methods
11/14/2006US7135318 Modified reductase and its gene
11/14/2006US7135316 Escherichia coli having accession No. PTA 1579 and its use to produce polyhydroxybutyrate